Watchlist Manager

Watchlist

Price: 55.2 CNY -3.26% Market Closed

Market Cap: ¥352.1B

	Jiangsu Hengrui Pharmaceuticals Co Ltd SSE:600276	CN
	Skako A/S CSE:SKAKO	DK
F	Fujian South Highway Machinery Co Ltd SSE:603280	CN
	Abdulmohsen Al Hokair Group for Tourism and Development Company CJSC SAU:1820	SA

Income Statement

Currency: CNY

	Dec-2003	Mar-2004	Jun-2004	Sep-2004	Dec-2004	Mar-2005	Jun-2005	Sep-2005	Dec-2005	Mar-2006	Jun-2006	Sep-2006	Dec-2006	Mar-2007	Jun-2007	Sep-2007	Dec-2007	Mar-2008	Jun-2008	Sep-2008	Dec-2008	Mar-2009	Jun-2009	Sep-2009	Dec-2009	Mar-2010	Jun-2010	Sep-2010	Dec-2010	Mar-2011	Jun-2011	Sep-2011	Dec-2011	Mar-2012	Jun-2012	Sep-2012	Dec-2012	Mar-2013	Jun-2013	Sep-2013	Dec-2013	Mar-2014	Jun-2014	Sep-2014	Dec-2014	Mar-2015	Jun-2015	Sep-2015	Dec-2015	Mar-2016	Jun-2016	Sep-2016	Dec-2016	Mar-2017	Jun-2017	Sep-2017	Dec-2017	Mar-2018	Jun-2018	Sep-2018	Dec-2018	Mar-2019	Jun-2019	Sep-2019	Dec-2019	Mar-2020	Jun-2020	Sep-2020	Dec-2020	Mar-2021	Jun-2021	Sep-2021	Dec-2021	Mar-2022	Jun-2022	Sep-2022	Dec-2022	Mar-2023	Jun-2023	Sep-2023	Dec-2023	Mar-2024	Jun-2024	Sep-2024	Dec-2024	Mar-2025	Jun-2025	Sep-2025	Dec-2025
Revenue
Interest Expense	17	0	0	0	11	0	0	0	3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5	0	0	0	7	0	0	0	5	0	0	0	5	1	2	0	6	6	8	9	6	0	6	0	6	16	0	0	14
Revenue	1 050 N/A	1 127 +7%	1 169 +4%	1 181 +1%	1 145 -3%	1 137 -1%	1 109 -2%	1 131 +2%	1 179 +4%	1 227 +4%	1 280 +4%	1 351 +6%	1 437 +6%	1 501 +4%	1 658 +10%	1 775 +7%	1 981 +12%	2 156 +9%	2 257 +5%	2 360 +5%	2 393 +1%	2 506 +5%	2 624 +5%	2 817 +7%	3 029 +8%	3 260 +8%	3 469 +6%	3 632 +5%	3 744 +3%	3 921 +5%	4 041 +3%	4 249 +5%	4 550 +7%	4 771 +5%	4 995 +5%	5 271 +6%	5 435 +3%	5 577 +3%	5 794 +4%	5 933 +2%	6 203 +5%	6 443 +4%	6 744 +5%	7 156 +6%	7 452 +4%	7 935 +6%	8 328 +5%	8 833 +6%	9 316 +5%	9 781 +5%	10 209 +4%	10 709 +5%	11 094 +4%	11 595 +5%	12 159 +5%	12 896 +6%	13 836 +7%	14 523 +5%	15 252 +5%	16 228 +6%	17 418 +7%	18 528 +6%	19 683 +6%	21 904 +11%	23 289 +6%	23 849 +2%	24 571 +3%	25 757 +5%	27 735 +8%	29 137 +5%	29 723 +2%	28 521 -4%	25 906 -9%	24 455 -6%	22 836 -7%	21 652 -5%	21 275 -2%	21 289 +0%	22 216 +4%	22 344 +1%	22 820 +2%	23 325 +2%	25 252 +8%	25 995 +3%	27 985 +8%	29 193 +4%	30 145 +3%	30 983 +3%	31 629 +2%
Gross Profit
Cost of Revenue	(362)	(376)	(346)	(320)	(304)	(259)	(237)	(236)	(249)	(274)	(285)	(301)	(302)	(300)	(331)	(346)	(363)	(398)	(430)	(437)	(439)	(463)	(451)	(491)	(569)	(598)	(630)	(662)	(662)	(715)	(746)	(800)	(853)	(890)	(911)	(929)	(874)	(982)	(1 161)	(1 235)	(1 159)	(1 348)	(1 330)	(1 373)	(1 316)	(1 499)	(1 491)	(1 521)	(1 372)	(1 555)	(1 561)	(1 611)	(1 433)	(1 686)	(1 813)	(1 946)	(1 851)	(2 221)	(2 302)	(2 430)	(2 338)	(2 706)	(2 839)	(3 038)	(2 918)	(3 199)	(3 173)	(3 378)	(3 356)	(3 782)	(3 993)	(3 918)	(3 756)	(3 882)	(3 865)	(3 871)	(3 503)	(3 682)	(3 775)	(3 685)	(3 562)	(3 835)	(3 854)	(3 930)	(3 881)	(4 234)	(4 357)	(4 497)	(4 381)
Gross Profit	689 N/A	751 +9%	823 +10%	861 +5%	841 -2%	878 +4%	872 -1%	895 +3%	930 +4%	952 +2%	995 +4%	1 050 +6%	1 135 +8%	1 201 +6%	1 328 +11%	1 429 +8%	1 618 +13%	1 759 +9%	1 827 +4%	1 923 +5%	1 954 +2%	2 043 +5%	2 174 +6%	2 326 +7%	2 460 +6%	2 662 +8%	2 840 +7%	2 970 +5%	3 082 +4%	3 206 +4%	3 296 +3%	3 450 +5%	3 698 +7%	3 881 +5%	4 084 +5%	4 342 +6%	4 562 +5%	4 596 +1%	4 632 +1%	4 698 +1%	5 044 +7%	5 095 +1%	5 415 +6%	5 783 +7%	6 137 +6%	6 436 +5%	6 837 +6%	7 312 +7%	7 944 +9%	8 226 +4%	8 648 +5%	9 098 +5%	9 661 +6%	9 908 +3%	10 346 +4%	10 950 +6%	11 984 +9%	12 303 +3%	12 950 +5%	13 798 +7%	15 080 +9%	15 821 +5%	16 845 +6%	18 866 +12%	20 370 +8%	20 650 +1%	21 398 +4%	22 379 +5%	24 379 +9%	25 355 +4%	25 730 +1%	24 602 -4%	22 150 -10%	20 573 -7%	18 971 -8%	17 781 -6%	17 772 0%	17 607 -1%	18 441 +5%	18 659 +1%	19 257 +3%	19 490 +1%	21 398 +10%	22 066 +3%	24 104 +9%	24 959 +4%	25 788 +3%	26 487 +3%	27 249 +3%
Operating Income
Operating Expenses	(534)	(584)	(650)	(673)	(653)	(677)	(654)	(675)	(704)	(713)	(744)	(788)	(864)	(898)	(1 024)	(1 048)	(1 252)	(1 317)	(1 288)	(1 399)	(1 340)	(1 402)	(1 533)	(1 686)	(1 771)	(1 942)	(2 052)	(2 097)	(2 249)	(2 293)	(2 348)	(2 475)	(2 668)	(2 811)	(2 942)	(3 146)	(3 279)	(3 278)	(3 268)	(3 288)	(3 619)	(3 609)	(3 883)	(4 180)	(4 446)	(4 570)	(4 805)	(5 119)	(5 532)	(5 682)	(6 006)	(6 329)	(6 819)	(6 911)	(7 163)	(7 588)	(8 256)	(8 409)	(8 871)	(9 509)	(10 852)	(11 341)	(12 106)	(13 778)	(14 705)	(14 837)	(15 460)	(16 064)	(17 916)	(18 711)	(19 174)	(18 191)	(18 118)	(16 896)	(15 818)	(15 237)	(14 215)	(14 462)	(15 014)	(15 049)	(14 724)	(14 722)	(15 614)	(16 225)	(17 325)	(17 613)	(17 771)	(18 372)	(18 718)
Selling, General & Administrative	(538)	(589)	(655)	(676)	(657)	(685)	(662)	(684)	(716)	(719)	(748)	(777)	(862)	(897)	(1 016)	(1 055)	(1 227)	(1 289)	(1 267)	(1 378)	(1 307)	(1 374)	(1 506)	(1 659)	(1 781)	(1 943)	(2 042)	(2 081)	(2 226)	(2 278)	(2 341)	(2 461)	(2 670)	(2 794)	(2 922)	(3 197)	(2 711)	(3 327)	(3 322)	(3 284)	(3 018)	(3 609)	(3 886)	(4 179)	(3 750)	(4 558)	(4 788)	(5 107)	(4 591)	(5 675)	(6 000)	(6 327)	(5 588)	(6 914)	(7 168)	(7 576)	(6 599)	(8 574)	(9 034)	(8 953)	(8 303)	(9 117)	(9 151)	(10 134)	(10 959)	(10 992)	(11 337)	(11 900)	(13 104)	(13 425)	(13 660)	(12 632)	(12 380)	(11 588)	(10 659)	(10 327)	(9 833)	(9 559)	(10 144)	(10 120)	(10 083)	(10 118)	(10 381)	(10 887)	(11 042)	(11 055)	(11 378)	(11 793)	(12 101)
Research & Development	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	(535)	0	0	0	(563)	0	0	0	(652)	0	0	0	(892)	0	0	0	(1 184)	0	0	0	(1 759)	0	0	(741)	(2 527)	(2 337)	(3 159)	(3 834)	(3 661)	(4 046)	(4 276)	(4 341)	(4 821)	(5 494)	(5 706)	(5 787)	(5 745)	(5 634)	(5 547)	(5 299)	(4 662)	(5 028)	(5 034)	(5 115)	(4 662)	(5 025)	(5 660)	(5 777)	(6 304)	(6 896)	(6 773)	(6 979)	(6 666)
Depreciation & Amortization	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	(32)	0	0	0	(37)	0	0	0	(43)	0	0	0	(48)	0	0	0	(45)	0	0	0	(51)	0	0	0	(191)	0	0	0	(272)	0	0	0	(196)	0	0	0	(260)	0	0	0	(263)	0	0	0	(405)	0	0	0	(357)	0	0	0	(394)
Other Operating Expenses	4	5	4	3	4	9	8	9	11	6	4	(11)	(1)	0	(7)	7	(25)	(28)	(21)	(21)	(33)	(28)	(27)	(27)	10	1	(10)	(16)	(23)	(15)	(7)	(14)	2	(18)	(20)	51	(1)	49	53	(4)	(1)	0	4	(1)	(1)	(12)	(17)	(12)	(1)	(7)	(7)	(2)	(2)	4	5	(11)	154	165	163	185	167	113	204	189	187	201	153	177	207	208	191	228	267	326	388	389	542	125	163	185	426	422	426	439	379	338	379	400	444
Operating Income	155 N/A	167 +8%	172 +3%	189 +9%	188 0%	201 +7%	218 +8%	219 +0%	226 +3%	240 +6%	251 +5%	262 +4%	271 +3%	303 +12%	304 +0%	381 +25%	366 -4%	441 +21%	539 +22%	524 -3%	614 +17%	641 +4%	640 0%	640 N/A	689 +8%	720 +4%	787 +9%	873 +11%	833 -5%	913 +10%	948 +4%	975 +3%	1 030 +6%	1 070 +4%	1 142 +7%	1 196 +5%	1 282 +7%	1 318 +3%	1 364 +3%	1 409 +3%	1 425 +1%	1 486 +4%	1 532 +3%	1 603 +5%	1 690 +5%	1 866 +10%	2 032 +9%	2 194 +8%	2 412 +10%	2 544 +5%	2 641 +4%	2 769 +5%	2 842 +3%	2 997 +5%	3 184 +6%	3 363 +6%	3 729 +11%	3 894 +4%	4 079 +5%	4 289 +5%	4 228 -1%	4 481 +6%	4 739 +6%	5 088 +7%	5 666 +11%	5 813 +3%	5 938 +2%	6 315 +6%	6 463 +2%	6 644 +3%	6 556 -1%	6 411 -2%	4 032 -37%	3 677 -9%	3 154 -14%	2 544 -19%	3 557 +40%	3 145 -12%	3 426 +9%	3 610 +5%	4 533 +26%	4 768 +5%	5 784 +21%	5 840 +1%	6 779 +16%	7 346 +8%	8 017 +9%	8 114 +1%	8 531 +5%
Pre-Tax Income
Interest Income Expense	(15)	(15)	(17)	(9)	(10)	(5)	2	(2)	0	1	0	2	19	19	33	34	137	59	39	19	(164)	(47)	(9)	(2)	83	47	16	29	12	13	12	16	17	14	16	15	18	15	16	15	26	32	53	73	82	98	107	111	147	160	167	178	182	165	170	170	77	130	168	234	367	351	421	451	483	544	583	569	541	549	423	471	629	549	682	699	649	939	849	782	444	430	538	473	706	590	642	650	524
Non-Reccuring Items	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	(1)	0	(1)	0	2	2	2	3	2	2	2	2	1	1	1	1	3	3	4	5	2	3	1	1	(94)	6	9	10	(67)	4	3	1	0	5	6	6	(70)
Gain/Loss on Disposition of Assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	(1)	0	0	0	0	0	0	0	0	0	0	0	(3)	0	(0)	(0)	0	(5)	(5)	(5)	(6)	(2)	(2)	(2)	0	(0)	0	2	(1)	0	0	0	(1)	0	0	0	(2)	0	0	0	(2)	0	0	0	0	0	0	0	(1)	0	0	0	(6)	0	0	0	0	0	0	0	0
Total Other Income	11	10	8	7	(6)	(5)	(2)	(3)	(5)	(5)	(5)	(4)	0	(1)	(0)	2	4	4	1	7	20	21	24	16	9	9	10	11	16	15	19	19	33	34	48	55	46	45	25	18	31	28	29	26	28	26	25	26	9	10	8	6	(10)	(7)	(5)	(2)	(48)	(56)	(75)	(96)	(97)	(108)	(121)	(107)	(92)	(109)	(137)	(190)	(109)	(110)	(120)	(104)	(197)	(171)	(146)	(172)	(142)	(163)	(154)	(155)	(237)	(357)	(418)	(372)	(316)	(198)	(196)	(275)	(277)
Pre-Tax Income	151 N/A	161 +7%	163 +1%	187 +15%	173 -7%	192 +11%	218 +14%	214 -2%	221 +3%	235 +6%	246 +4%	259 +6%	289 +11%	321 +11%	337 +5%	418 +24%	507 +21%	504 -1%	579 +15%	550 -5%	470 -14%	615 +31%	655 +7%	654 0%	781 +19%	776 -1%	814 +5%	913 +12%	860 -6%	941 +9%	978 +4%	1 010 +3%	1 079 +7%	1 117 +4%	1 206 +8%	1 265 +5%	1 346 +6%	1 378 +2%	1 405 +2%	1 442 +3%	1 479 +3%	1 546 +5%	1 614 +4%	1 701 +5%	1 800 +6%	1 984 +10%	2 158 +9%	2 325 +8%	2 562 +10%	2 712 +6%	2 814 +4%	2 951 +5%	3 013 +2%	3 155 +5%	3 348 +6%	3 532 +6%	3 759 +6%	3 970 +6%	4 175 +5%	4 430 +6%	4 499 +2%	4 726 +5%	5 042 +7%	5 434 +8%	6 056 +11%	6 250 +3%	6 386 +2%	6 695 +5%	6 895 +3%	7 086 +3%	6 863 -3%	6 783 -1%	4 466 -34%	4 059 -9%	3 691 -9%	3 071 -17%	3 968 +29%	3 928 -1%	4 129 +5%	4 247 +3%	4 667 +10%	4 845 +4%	5 906 +22%	5 941 +1%	7 170 +21%	7 743 +8%	8 469 +9%	8 495 +0%	8 708 +3%
Net Income
Tax Provision	(58)	(63)	(50)	(46)	(51)	(61)	(76)	(73)	(61)	(64)	(53)	(73)	(84)	(92)	(82)	(110)	(86)	(83)	(120)	(104)	(34)	(37)	(33)	(9)	(87)	(92)	(100)	(129)	(105)	(128)	(133)	(124)	(125)	(125)	(170)	(184)	(195)	(200)	(185)	(192)	(186)	(199)	(196)	(205)	(227)	(253)	(284)	(305)	(338)	(363)	(355)	(387)	(379)	(397)	(441)	(459)	(466)	(512)	(531)	(569)	(438)	(444)	(512)	(593)	(729)	(811)	(820)	(859)	(587)	(587)	(544)	(525)	18	137	199	317	(153)	(88)	(92)	(77)	(389)	(433)	(491)	(498)	(833)	(897)	(1 105)	(1 014)	(991)
Income from Continuing Operations	92	99	113	141	121	131	143	142	160	172	193	186	205	229	255	308	420	421	459	445	436	578	623	645	693	684	714	784	755	813	846	886	955	992	1 036	1 082	1 151	1 178	1 220	1 250	1 292	1 347	1 417	1 496	1 573	1 732	1 875	2 021	2 224	2 349	2 459	2 564	2 634	2 759	2 907	3 073	3 293	3 459	3 644	3 862	4 061	4 282	4 530	4 841	5 326	5 439	5 566	5 836	6 309	6 499	6 319	6 258	4 484	4 196	3 890	3 388	3 815	3 840	4 037	4 170	4 278	4 412	5 416	5 443	6 337	6 846	7 364	7 481	7 717
Income to Minority Interest	2	3	(2)	(2)	1	3	5	5	2	2	1	3	2	0	(2)	(7)	(6)	(7)	(8)	(7)	(13)	(16)	(19)	(23)	(28)	(28)	(30)	(28)	(31)	(37)	(45)	(53)	(64)	(68)	(70)	(73)	(74)	(66)	(58)	(51)	(54)	(56)	(61)	(67)	(57)	(59)	(58)	(50)	(52)	(40)	(34)	(36)	(45)	(42)	(59)	(85)	(76)	(104)	(91)	(61)	4	27	38	47	2	12	12	16	19	10	15	19	46	74	92	108	91	68	58	37	25	20	10	5	(0)	(4)	(9)	(13)	(6)
Equity Earnings Affiliates	0	0	0	(15)	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net Income (Common)	95 N/A	101 +7%	110 +9%	124 +12%	123 -1%	133 +8%	148 +11%	162 +10%	162 +0%	174 +7%	193 +11%	188 -3%	207 +10%	229 +11%	253 +10%	300 +19%	415 +38%	414 0%	451 +9%	438 -3%	423 -3%	561 +33%	604 +8%	621 +3%	666 +7%	656 -1%	684 +4%	756 +11%	724 -4%	775 +7%	801 +3%	833 +4%	891 +7%	924 +4%	966 +5%	1 009 +4%	1 077 +7%	1 112 +3%	1 162 +5%	1 199 +3%	1 238 +3%	1 292 +4%	1 356 +5%	1 429 +5%	1 516 +6%	1 673 +10%	1 817 +9%	1 970 +8%	2 172 +10%	2 309 +6%	2 425 +5%	2 529 +4%	2 589 +2%	2 717 +5%	2 848 +5%	2 988 +5%	3 217 +8%	3 354 +4%	3 553 +6%	3 801 +7%	4 066 +7%	4 309 +6%	4 568 +6%	4 889 +7%	5 328 +9%	5 451 +2%	5 577 +2%	5 852 +5%	6 328 +8%	6 510 +3%	6 334 -3%	6 277 -1%	4 530 -28%	4 271 -6%	3 982 -7%	3 496 -12%	3 906 +12%	3 908 +0%	4 095 +5%	4 207 +3%	4 302 +2%	4 432 +3%	5 426 +22%	5 448 +0%	6 337 +16%	6 842 +8%	7 355 +8%	7 468 +2%	7 711 +3%
EPS (Diluted)	0.02 N/A	0.01 -50%	0.01 N/A	0.02 +100%	0.02 N/A	0.03 +50%	0.04 +33%	0.04 N/A	0.03 -25%	0.04 +33%	0.04 N/A	0.04 N/A	0.03 -25%	0.04 +33%	0.04 N/A	0.05 +25%	0.07 +40%	0.07 N/A	0.08 +14%	0.07 -12%	0.07 N/A	0.08 +14%	0.09 +12%	0.1 +11%	0.11 +10%	0.11 N/A	0.11 N/A	0.12 +9%	0.12 N/A	0.13 +8%	0.13 N/A	0.13 N/A	0.14 +8%	0.14 N/A	0.15 +7%	0.16 +7%	0.17 +6%	0.17 N/A	0.18 +6%	0.19 +6%	0.2 +5%	0.21 +5%	0.22 +5%	0.23 +5%	0.24 +4%	0.27 +13%	0.29 +7%	0.31 +7%	0.41 +32%	0.38 -7%	0.4 +5%	0.42 +5%	0.41 -2%	0.43 +5%	0.45 +5%	0.47 +4%	0.51 +9%	0.53 +4%	0.56 +6%	0.6 +7%	0.64 +7%	0.68 +6%	0.72 +6%	0.77 +7%	0.84 +9%	0.86 +2%	0.88 +2%	0.92 +5%	1 +9%	1.03 +3%	1 -3%	1 N/A	0.71 -29%	0.67 -6%	0.62 -7%	0.55 -11%	0.61 +11%	0.62 +2%	0.64 +3%	0.68 +6%	0.68 N/A	0.7 +3%	0.85 +21%	0.85 N/A	1 +18%	1.08 +8%	1.16 +7%	1.11 -4%	1.18 +6%

Income Statement Balance Sheet Cash Flow Statement

Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276

Income Statement

Earnings Waterfall
Jiangsu Hengrui Pharmaceuticals Co Ltd

Income Statement
Jiangsu Hengrui Pharmaceuticals Co Ltd

See Also

Company

Help

Tools

Stocks

Jiangsu Hengrui Pharmaceuticals Co Ltd SSE:600276

Income Statement

Earnings Waterfall Jiangsu Hengrui Pharmaceuticals Co Ltd

Income Statement Jiangsu Hengrui Pharmaceuticals Co Ltd

See Also

Company

Help

Tools

Stocks

Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276

Earnings Waterfall
Jiangsu Hengrui Pharmaceuticals Co Ltd

Income Statement
Jiangsu Hengrui Pharmaceuticals Co Ltd